Gut microbes as biomarkers of ICI response - sharpening the focus.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

9 citing papers in PubMed.

1. Lachnospiraceae in the Food-Gut Axis: A Critical Review of Dietary Modulation, Immune Regulation, and Translational Barriers.Comprehensive reviews in food science and food safety · 2026
   Review
2. Updates on radiotherapy-immunotherapy combinations: Proceedings of 8th Annual ImmunoRad Conference.Oncoimmunology · 2025
   Article
3. Focus on gut microbes: new direction in cancer treatment.Frontiers in oncology · 2025
   Review
4. Current approaches in glioblastoma multiforme immunotherapy.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2024
   Review
5. Immunotherapy: remember the host.Translational lung cancer research · 2023
   Article
6. Orchestrating smart therapeutics to achieve optimal treatment in small cell lung cancer: recent progress and future directions.Journal of translational medicine · 2023
   Review
7. Immune Checkpoint Inhibitors and the Exposome: Host-Extrinsic Factors Determine Response, Survival, and Toxicity.Cancer research · 2023
   Review
8. An emerging strategy: probiotics enhance the effectiveness of tumor immunotherapy via mediating the gut microbiome.Gut microbes
   Review
9. Therapeutic potential ofGut microbes
   Article

Corrections and comments

• Comment on
  Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanoma.2022
• Comment on
  Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1.2022

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as